Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec 16;91(1):e01339-16.
doi: 10.1128/JVI.01339-16. Print 2017 Jan 1.

Importance of Highly Conserved Peptide Sites of Human Cytomegalovirus gO for Formation of the gH/gL/gO Complex

Affiliations

Importance of Highly Conserved Peptide Sites of Human Cytomegalovirus gO for Formation of the gH/gL/gO Complex

Cora Stegmann et al. J Virol. .

Abstract

The glycoprotein O (gO) is betaherpesvirus specific. Together with the viral glycoproteins H and L, gO forms a covalent trimeric complex that is part of the viral envelope. This trimer is crucial for cell-free infectivity of human cytomegalovirus (HCMV) but dispensable for cell-associated spread. We hypothesized that the amino acids that are conserved among gOs of different cytomegaloviruses are important for the formation of the trimeric complex and hence for efficient virus spread. In a mutational approach, nine peptide sites, containing all 13 highly conserved amino acids, were analyzed in the context of HCMV strain TB40-BAC4 with regard to infection efficiency and formation of the gH/gL/gO complex. Mutation of amino acids (aa) 181 to 186 or aa 193 to 198 resulted in the loss of the trimer and a complete small-plaque phenotype, whereas mutation of aa 108 or aa 249 to 254 caused an intermediate phenotype. While individual mutations of the five conserved cysteines had little impact, their relevance was revealed in a combined mutation, which abrogated both complex formation and cell-free infectivity. C343 was unique, as it was sufficient and necessary for covalent binding of gO to gH/gL. Remarkably, however, C218 together with C167 rescued infectivity in the absence of detectable covalent complex formation. We conclude that all highly conserved amino acids contribute to the function of gO to some extent but that aa 181 to 198 and cysteines 343, 218, and 167 are particularly relevant. Surprisingly, covalent binding of gO to gH/gL is required neither for its incorporation into virions nor for proper function in cell-free infection.

Importance: Like all herpesviruses, the widespread human pathogen HCMV depends on glycoproteins gB, gH, and gL for entry into target cells. Additionally, gH and gL have to bind gO in a trimeric complex for efficient cell-free infection. Homologs of gO are shared by all cytomegaloviruses, with 13 amino acids being highly conserved. In a mutational approach we analyzed these amino acids to elucidate their role in the function of gO. All conserved amino acids contributed either to formation of the trimeric complex or to cell-free infection. Notably, these two phenotypes were not inevitably linked as the mutation of a charged cluster in the center of gO abrogated cell-free infection while trimeric complexes were still being formed. Cysteine 343 was essential for covalent binding of gO to gH/gL; however, noncovalent complex formation in the absence of cysteine 343 also allowed for cell-free infectivity.

Keywords: cell tropism; cytomegalovirus; glycoprotein O; glycoproteins; mutational studies.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Growth characteristics of a novel TB40-BAC4-UL74stop mutant.(A) Focus formation was allowed for 5 days before infected cells were stained for viral IE antigens (magenta). Nuclei were stained with DAPI (blue). (B) Cell-free infectivity of wild-type and UL74stop in endothelial cells (HECs) and fibroblasts (HFFs). Supernatants of UL74stop were concentrated 60-fold (60×) by ultracentrifugation in order to analyze the tropism of the UL74stop virus. Infection rates were determined by calculating the ratio of IE-positive nuclei to the total number of nuclei.
FIG 2
FIG 2
TEM images of TB40-BAC4. (A) An overview of an infected fibroblast showing both the nucleus and the cytoplasm. The boxed rectangle in the cytoplasm marks an area in the perinuclear assembly compartment which is magnified further in panel B, where various HCMV particles are visible. Panel C shows the boxed area of panel B at still higher magnification. Virion particles undergoing envelopment as well as completely enveloped particles in vesicles are visible.
FIG 3
FIG 3
TEM images of TB40-BAC4-UL74stop. Similar to the images in Fig. 2, panel A shows an overview of a late-stage-infected fibroblast. The boxed area shows the perinuclear assembly compartment, which is shown at higher magnification in panel B. The four virus particles from this image are further magnified in panel C to allow discrimination of enveloped particles and particles in the process of envelopment.
FIG 4
FIG 4
Alignment of pUL74 sequences from CMVs infecting different species. The percentage of conservation is indicated as a bar for each amino acid. Matching amino acids are displayed as dots. The red frames indicate the peptide sites that were chosen for mutation, including the 13 highly conserved amino acids.
FIG 5
FIG 5
Alignment of pUL74 sequences from different HCMV strains. The percentage of conservation is indicated as a bar for each amino acid. Matching amino acids are displayed as dots. The red frames indicate the sites that were mutated.
FIG 6
FIG 6
Impact of highly conserved peptide sites within pUL74 on virus growth. (A) Representative images of foci formed in fibroblasts at 5 days posttransfection. Nuclei stained for the viral IE antigens are shown in magenta; DAPI-stained nuclei of noninfected cells are blue. (B) Growth of virus mutants was analyzed starting at day 7 posttransfection by measuring the infection rates within aliquots of transfected cultures. (C) For quantification of the spreading capacities of the virus mutants, infected fibroblasts (HFFs) were cocultured with noninfected HFFs or endothelial cells (HECs) for 5 days. Focus size was determined by staining for viral IE antigens and subsequent counting of the number of infected cells per focus. As not all nine peptide site mutants could be tested in both cell types at the same time, the results obtained in the different experiments were normalized to the wild-type values in the respective experiments. For each mutant the mean values of three independent experiments are shown. Error bars indicate standard errors of the means of the normalized values. (D) For comparison of the cell-free infectivity, supernatants of pUL74 mutants and controls (wild type and UL74stop) were used to infect HFFs and HECs in parallel. Infection rates were calculated from the number of IE-positive nuclei to the total number of nuclei (DAPI). The mean values of the infection rates in HFFs and HECs in at least three experiments were compared to those of wild-type virus in the respective experiments by an unpaired t test. (*, <0.05; **, <0.01; ***, <0.001). Error bars indicate standard errors of the means.
FIG 7
FIG 7
Focal growth of virus revertants. Infected fibroblasts were cocultured with noninfected fibroblasts for 5 days. Focus size was determined by staining for viral IE antigens and subsequent counting of the number of infected cells per focus. Mean focus expansion values of three independent experiments are shown; error bars indicate standard errors of the means.
FIG 8
FIG 8
Importance of highly conserved peptide sites for formation of the gH/gL/gO complex and gO maturation. Infected fibroblasts were lysed when cultures showed >90% late-stage cytopathic effects. Lysates were analyzed either under reducing conditions to display gO accumulation in the cells or under nonreducing conditions to test for formation of the gH/gL/gO complex. Detection of gB was included to visualize the content of HCMV glycoproteins in each sample.
FIG 9
FIG 9
Cysteine 343 can rescue virus growth and complex formation. (A) Growth properties of mutants either lacking all five cysteines (5CtoA) or lacking four cysteines (4CtoA) were characterized during reconstitution. Infection rates were determined from aliquots of transfected cultures twice weekly, starting at day 2 posttransfection. Wild-type virus and UL74stop virus were included as references. (B) For analysis of the spreading capacities of the virus mutants, infected fibroblasts were cocultured with noninfected fibroblasts for 5 days. Focus size was quantified by staining for viral IE antigens and subsequent counting of the number of infected cells per focus. Mean focus expansion values of four independent experiments are shown. Error bars indicate standard errors of the means. A one-sided, paired t test was used to compare the different viruses with the UL74stop control (*, P < 0.5; **, P < 0.01). (C) In order to test for gO accumulation and complex formation, lysates of infected fibroblasts were subjected to SDS-PAGE under reducing and nonreducing conditions, respectively. Detection of actin served as a loading control. A staining for gB was included to control for the amount of HCMV glycoproteins in each sample.
FIG 10
FIG 10
Characterization of the C343A mutant. (A) Virus growth was measured starting at day 2 posttransfection. The infection rates were determined over time in aliquots of the transfected cells by staining for the viral IE antigens. (B) To test whether the gH/gL/gO complex is also undetectable in a mutant lacking only C343, infected cells were subjected to SDS-PAGE under nonreducing conditions. The same lysates were also analyzed under reducing conditions to control for protein accumulation independent of complex formation.
FIG 11
FIG 11
C343A virions contain large amounts of gO. (A) Gradient-purified virions were lysed and subjected to gel electrophoresis under nonreducing conditions to test whether the trimeric complex is detectable. Aliquots of the same virion preparation were analyzed in parallel under reducing conditions and probed against the viral proteins gO, gB, gL, and pUL128. (B) For coimmunoprecipitation, lysates of gradient-purified virions were either incubated with protein A-Sepharose alone (preclear) or with anti-gH antibody 14-4b and protein A-Sepharose (IP). The precipitated proteins were analyzed under reducing conditions. To control for input in each sample, gH was detected after stripping of the membrane.
FIG 12
FIG 12
Either C343 or C167 and C218 are needed for efficient virus growth. (A) Growth of virus mutants was analyzed starting at day 6 posttransfection by measuring the infection rates within aliquots of transfected cultures. (B) Analysis of focal growth in fibroblasts (HFFs) and endothelial cells (HECs) over 5 days. Focus size was determined by counting the number of IE-positive nuclei per focus. The mean focus size of virus mutants in three independent experiments was compared to that of the wild type with a paired t test (*, P < 0.5). Error bars indicate standard errors of the means. (C) The virus mutants were analyzed regarding formation of the trimeric complex and gO accumulation by SDS-PAGE of cell lysates under nonreducing and reducing conditions, respectively. gB and gL served as internal controls for the content of viral glycoproteins in each sample.

Similar articles

Cited by

References

    1. Kenneson A, Cannon MJ. 2007. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17:253–276. doi:10.1002/rmv.535. - DOI - PubMed
    1. Naing ZW, Scott GM, Shand A, Hamilton ST, van Zuylen WJ, Basha J, Hall B, Craig ME, Rawlinson WD. 2016. Congenital cytomegalovirus infection in pregnancy: a review of prevalence, clinical features, diagnosis and prevention. Aust N Z J Obstet Gynaecol 56:9–18. doi:10.1111/ajo.12408. - DOI - PubMed
    1. Pass RF. 1996. Immunization strategy for prevention of congenital cytomegalovirus infection. Infect Agents Dis 5:240–244. - PubMed
    1. Desai R, Collett D, Watson CJ, Johnson PJ, Moss P, Neuberger J. 2015. Impact of cytomegalovirus on long-term mortality and cancer risk after organ transplantation. Transplantation 99:1989–1994. doi:10.1097/TP.0000000000000641. - DOI - PubMed
    1. Limaye AP, Bakthavatsalam R, Kim HW, Randolph SE, Halldorson JB, Healey PJ, Kuhr CS, Levy AE, Perkins JD, Reyes JD, Boeckh M. 2006. Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis. Transplantation 81:1645–1652. doi:10.1097/01.tp.0000226071.12562.1a. - DOI - PubMed

MeSH terms

LinkOut - more resources